Market Overview

SOHM, Inc. Announces No Reverse Split and No Increase of Authorize Shares

Share:

Chino Hills, CA, July 24, 2018 (GLOBE NEWSWIRE) -- SOHM, Inc. (OTC:SHMN), a globally-known generic pharmaceutical manufacturer, would like to clarify certain information and facts as following. Our current Share Structure is as follows: Outstanding Shares 1,547,798,629 as of June 13, 2018; Shares in the Float 1,247,784,441 as of June 13, 2018.

We have received requests from some shareholders to clarify about some investors sharing falsely made claims about the company and its operation on various company boards.  We would like to clarify some of them that;

(a) Company has not exercised any reverse splits in the last 10 years. SOHM, Inc. did a reverse split when we took over management of the company from previous management team back in August 2008. After that SOHM, Inc. has not exercised any reverse splits. Back in November 2017 we cancelled our only possible reverse split through a press release.  Again, currently our management team is not considering any reverse split in the interest of every stakeholder including investors. It had confirmed also again a few days back.

(b) They also claim that company revenues for Q1 is through selling of company stocks, which is again made with some personal interest or grudges it seems. It is completely misguiding with vested interest. Company revenue is through its selling of products and services.

(c) Their claims are that company has issued approx. 545 million stocks in last 5 months, which is again false. After August 2015, the company has not issued any stocks including to any of its directors or promoters except in April 2018 when the company has honored one of its old notes and stock issued were approx. 108 million.

(d) Company is working with its counsel to work with OTC to satisfy its compliance to move to Current and in the appropriate time when we come to know the progress, the company would inform its shareholders with updates.

We hope this insight clarifies major concerns of the shareholders. At the same time, we strongly recommend and request investors and shareholders do their own due diligence before investment in the company. Instead of answering every shareholder who communicates with us, we prefer to release our information through press releases.

We are committed to do whatever possible and within our reach to improve operations and bring more transparency in company updates like we have been doing since taking over the management back in 2008.

Management is working towards the company's development and we have reiterated it several times.

Thank you, all shareholders!

About SOHM, Inc.


SOHM, Inc., is a growing generic pharmaceutical manufacturing and marketing company with a global presence and marketing plan that assure continuous growth. SOHM manufacturing and marketing target the rapidly growing healthcare segments such as Nutraceuticals, Cosmeceuticals, and other major therapeutic segments. SOHM is headquartered in North America with manufacturing in India as well as strategic alliance with US manufacturing facilities. Although SOHM's generic pharmaceuticals are exported globally and was introduced to the USA in early 2013, SOHM continues its focus on distribution to emerging markets in Africa, Latin America, and Southeast Asia.
To know more about SOHM, Inc., visit www.SOHM.com

Safe Harbor Statement:
This news release contains "forward-looking statements", which are statements that are not purely historical and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on for the most recent fiscal year, our quarterly reports uploaded from time-to-time on OTCMarkets.com.


For more information, please contact:
SOHM, Inc.
714-522-6700

View Comments and Join the Discussion!